SCHEMBL5755265

SCHEMBL5755265

O=C(O)c1cccc2[nH]c(-c3cc[nH]n3)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 2/20 0.40
HDAC11 Q96DB2 1/20 0.38
PARP1 P09874 2/20 0.38
KDM4E B2RXH2 4/20 0.36
HPGD P15428 2/20 0.36
DHODH Q02127 5/20 0.36
NR4A1 P22736 1/20 0.36
NR4A2 P43354 1/20 0.36
NR4A3 Q92570 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.35
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NAPRT Q6XQN6 1/20 0.35
PTPN1 P18031 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5752743 0.88 PARP1 (0.40) HDAC11PARP1KDM4EDHODHALDH1A1
SCHEMBL5757017 0.84 HDAC11 (0.43) HDAC11KDM4EHPGDALDH1A1GAA
SCHEMBL5755838 0.84 BRAF (0.44) HDAC11KDM4EALDH1A1GAAKMT2A
SCHEMBL5752672 0.82 HDAC11 (0.41) HDAC11KDM4EHPGDALDH1A1KMT2A
SCHEMBL5756015 0.82 KDM4E (0.49) KDM4EALDH1A1POLBKMT2AMEN1
SCHEMBL5754686 0.81 KDR (0.43) HDAC11KDM4ECYP1A2MAPK1ITK
SCHEMBL5756316 0.81 KDM4E (0.53) KDM4EHPGDKMT2AMEN1GLA
SCHEMBL5752935 0.80 HRH4 (0.41) PARP1KDM4EALDH1A1GRIN2DGRIN3B
SCHEMBL6479227 0.80 HRH4 (0.38) KDM4EALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL5756543 0.80 HDAC11 (0.39) HDAC11KDM4EALDH1A1GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648884-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2006-04-26 EP disclosed
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed
WO-2005005414-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 PBRM1 1947/4885HDAC11 1178/4885PARP1 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.